원문정보
초록
영어
Glutathione S-transferases (GSTs) are important enzymes involved in phase II detoxification and function by conjugating with the thiol group of glutathione. In this study, we isolated an omega class GST from the big-belly seahorse (Hippocampus abdominalis; HaGSTO1) to study the putative xenobiotic responses and defense ability against viral and bacterial infections in this animal. The isolated HaGSTO1 gene, with a cording sequence of 720 bp, encodes a peptide of 239 amino acids. The predicted molecular mass and theoretical isoelectric point of HaGSTO1 was 27.47 kDa and 8.13, respectively. In-silico analysis of HaGSTO1 revealed a characteristic N-terminal thioredoxin-like domain and a C-terminal domain. Unlike other GSTs, the C-terminal of HaGSTO1 reached up to the N-terminal, and the N-terminal functional group was cysteine rather than tyrosine or serine, as observed in other GSTs. Phylogenetic analysis showed the evolutionary proximity of HaGSTO1 with other identified vertebrate and invertebrate GST orthologs. For the first time, we demonstrated the viral defense capability of HaGSTO1 against viral hemorrhagic septicemia virus (VHSV) infection. All six nucleoproteins of VHSV were significantly downregulated in HaGSTO1-overexpressing FHM cells at 24 h after infection compared with those in the control. Moreover, arsenic toxicity was significantly reduced in HaGSTO1-overexpressing FHM cells, and cell viability increased. Real-time polymerase chain reaction analysis showed that HaGSTO1 transcripts were highly expressed in the pouch and gill when compared with those in other tissues. Blood HaGSTO1 transcripts were significantly upregulated after Edwardsiella tarda, Streptococcus iniae, lipopolysaccharide, and polyinosinic: polycytidylic acid challenge experiments. Collectively, these findings suggest the involvement of HaGSTO1 in the host defense mechanism of seahorses.
목차
1. Introduction
2. Materials and methods
2.1. HaGSTO1 sequence identification and in-silico analysis
2.2. Seahorse acclimatization and tissue sampling
2.3. Immune challenge experiment
2.4. Total RNA extraction and cDNA synthesis
2.5. HaGSTO1 expression analysis
2.6. Cloning of HaGSTO1 into expression plasmids
2.7. Production and purification of recombinant HaGSTO1 (rHaGSTO1) fusion protein
2.8. Biochemical properties of rHaGSTO1
2.9. Cell viability in the presence of arsenic
2.10. Antiviral activity of HaGSTO1 in response to VHSV
3. Results and discussion
3.1. HaGSTO1 sequence characterization
3.2. Homology analysis of HaGSTO1
3.3. Analysis of the gene expression profile of HaGSTO1
3.4. Enzymatic activity of rHaGSTO1
3.5. Detoxification activity of HaGSTO1
3.6. Antiviral activity of HaGSTO1 against VHSV infection
4. Conclusion
References